Efficacy and Safety of Lu AA34893 in Patients With Major Depressive Disorder
- Status
- TERMINATED
- Phase
- PHASE2
Clinical Trials Related to Major Depressive Disorder
Related studies linked through entity extraction aliases.
Linköping University Relational and Interpersonal Psychotherapy Project
- Status
- TERMINATED
- Phase
- PHASE2
Open-label Safety Extension Study of 5 and 10 mg of Vortioxetine (Lu AA21004) in Long-term Treatment of Major Depressive Disorder in Adults
- Status
- COMPLETED
- Phase
- PHASE2
Electroencephalography (EEG) Biomarkers of Response in Depression
- Status
- COMPLETED
- Phase
- PHASE4
Stress Generation and Recurrent Depression: The Role of Differential Treatment Response
- Status
- COMPLETED
- Phase
- PHASE1
Patient Dimensions as Predictors of Varied Treatment Responses and Outcomes in Patients With Major Depression
- Status
- COMPLETED
- Phase
- PHASE2
Incorporating Patient Treatment Choice to Improve Treatment Retention in Depressed Hispanics
- Status
- COMPLETED
- Phase
- PHASE2
A Study of CX157 (TriRima) for the Treatment of Depression
- Status
- COMPLETED
- Phase
- PHASE2
Efficacy Study of Vortioxetine (Lu AA21004) in Adults With Major Depressive Disorder
- Status
- COMPLETED
- Phase
- PHASE3
Efficacy of SEROQUEL in Selective Serotonin Reuptake Inhibitors (SSRI)-Resistant Major Depressive Disorder
- Status
- COMPLETED
- Phase
- PHASE2
Open Label Extension Assessing the Tolerability of BCI-024 in Combination With BCI-049 in Patients With Major Depressive Disorder (MDD)
- Status
- COMPLETED
- Phase
- PHASE2
Creatine Augmentation Treatment in Major Depressive Disorder Subjects
- Status
- COMPLETED
- Phase
- NA
Quetiapine Extended Release (XR) for the Treatment of Menopausal Depression
- Status
- COMPLETED
- Phase
- PHASE4
Cysteamine Therapy for Major Depressive Disorder
- Status
- TERMINATED
- Phase
- NA
Fluoxetine vs. Brief Psychotherapy for Major Depression
- Status
- COMPLETED
- Phase
- NA
Safety and Tolerability of Vortioxetine (Lu AA21004) in Adults With Major Depressive Disorder
- Status
- COMPLETED
- Phase
- PHASE3
Exploring a Potential Blood Test to Diagnose Major Depressive Disorder
- Status
- COMPLETED
- Phase
- N/A
Efficacy and Safety Study of a Combination Product [Drug:BCI-024 (Buspirone) and Drug:BCI-049 (Melatonin)] to Treat Major Depressive Disorder (MDD)
- Status
- COMPLETED
- Phase
- PHASE2
Duloxetine Treatment of Major Depression and Chronic Low Back Pain For Older Adults
- Status
- COMPLETED
- Phase
- PHASE4
Open-label Safety Extension Study of 2.5, 5 and 10 mg of Vortioxetine (Lu AA21004) in Long-term Treatment of Major Depressive Disorder in Adults
- Status
- COMPLETED
- Phase
- PHASE3